Evaluating antibiograms to monitor drug resistance

Emerging Infectious Diseases

Volumn 11, Issue 8, 2005, Pages 1301-1302

  El Azizi, Mohamed ^a   Mushtaq, Adnan ^a   Drake, Cheryl ^b   Lawhorn, Jerry ^b   Barenfanger, Joan ^b   Verhulst, Steven ^a   Khardori, Nancy ^a,c  

^a SOUTHERN ILLINOIS UNIVERSITY   (United States)

^b MEMORIAL MEDICAL CENTER   (United States)

^c SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL INFECTION; DRUG MONITORING; DRUG SCREENING; EVALUATION; HUMAN; LABORATORY TEST; PATHOGENESIS; PRACTICE GUIDELINE; RISK ASSESSMENT;

EID: 22944442927     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid1108.050135     Document Type: Article

References (7)

1. Halstead DC, Gomez N, McCarter YS. Reality of developing a community-wide antibiogram. J Clin Microbiol. 2004;42:1-6.
2. NCCLS. Analysis and presentation of cumulative antimicrobial susceptibility test data. Document M39-A. Wayne (PA): The Committee; 2000.
3. Pfaller MA, Jones RN, Doern GV, Kugler K. Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997). Antimicrob Agents Chemother. 1998;42:1762-70.
4. Doern GV, Heilmann KP, Huynh HK, Rhomberg PR, Coffman SL, Brueggemann AB. Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000, including a comparison of resistance rates since 1994-1995. Antimicrob Agents Chemother. 2001;45:1721-9.
5. Stein CR, Weber DJ, Kelley M. Using hospital antibiogram data to assess regional pneumococcal resistance to antibiotics. Emerg Infect Dis. 2003;9:211-6.
6. Pfaller MA, Ehrhardt AF, Jones RN. Frequency of pathogen occurrence and antimicrobial susceptibility among community-acquired respiratory tract infections in the respiratory surveillance program study: microbiology from the medical office practice environment. Am J Med. 2001;111(Suppl 9A):4S-12S.
7. Chin AE, Hedberg K, Cieslak PR, Cassidy M, Stefonek KR, Fleming DW. Tracking drug-resistant Streptococcus pneumoniae in Oregon: an alternative surveillance method. Emerg Infect Dis. 1999;5:688-93.